US 7,482,335 B2
Cyclic derivatives as modulators of chemokine receptor activity
Percy H. Carter, Princeton, N.J. (US); Robert J. Cherney, Newtown, Pa. (US); Douglas G. Batt, Wilmington, Del. (US); John V. Duncia, Newtown, Pa. (US); Daniel S. Gardner, Furlong, Pa. (US); Soo S. Ko, Hockessin, Del. (US); Anurag S. Srivastava, Belle Mead, N.J. (US); and Michael G. Yang, Narberth, Pa. (US)
Assigned to Bristol-Myers Squibb Company, Princeton, N.J. (US)
Filed on Oct. 10, 2006, as Appl. No. 11/545,415.
Application 11/545415 is a division of application No. 10/923619, filed on Aug. 19, 2004, granted, now 7,163,937, filed on Jan. 16, 2007.
Claims priority of provisional application 60/496947, filed on Aug. 21, 2003.
Prior Publication US 2007/0032526 A1, Feb. 08, 2007
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/397 (2006.01); A61K 31/5383 (2006.01); A61K 31/496 (2006.01); A61K 31/454 (2006.01); A61K 31/4015 (2006.01); C07D 413/12 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 207/277 (2006.01); C07D 207/00 (2006.01); C07D 205/04 (2006.01)
U.S. Cl. 514—210.18  [514/237.2; 514/254.01; 514/326; 514/422; 544/141; 544/372; 546/208; 548/518; 548/953] 21 Claims
 
1. A compound of formula (I):

OG Complex Work Unit Drawing
or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein:
ring B is a cyclohexyl group wherein the cyclohexyl group is substituted with 1-2 R5;
X is selected from O or S;
Z is selected from —NR8C(O)—, —NR8C(S)—, —NR8C(O)NH—, —NR8C(S)NH—, —NR8SO2—, —NR8SO2NH—, —C(O)NR8—, —OC(O)NR8—, —NR8C(O)O—, —CR14═CR14—, —CR15R15—, —CR15R15C(O)—, —C(O)CR15R15—, —CR15R15C(═N—OR16)—, —O—CR14R14—, —CR14R14—O—, —O—, —NR9—, —NR9—CR14R14—, —CR14R14—NR9—, —S(O)p—, —S(O)p—CR14 R14, —CR14R14—S(O)p—, and —S(O)p—NR9—;
wherein neither Z nor R13 are connected to a carbon atom labeled (b);
bond (a) is a single bond or double bond;
R1 is selected from H, R6, C1-6 alkyl substituted with 0-3 R6, C2-6 alkenyl substituted with 0-3 R6, C2-6 alkynyl substituted with 0-3 R6, C6-10 aryl group substituted with 0-5 R6, wherein the aryl group is selected from phenyl and napthyl, and a 5-10 membered heteroaryl system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R6, wherein the heteroaryl is selected from indolyl, benzimidazolyl, benzofuranyl, benzothiofuranyl, benzoxazolyl, benzthiazolyl, benztriazolyl, benztetrazolyl, benzisoxazolyl, benzisothiazolyl, benzimidazalonyl, cinnolinyl, furanyl, imidazolyl, indazolyl, indolyl, isonicotinyl, isoquinolinyl isothiazolyl, isoxazolinyl, isoxazolyl, oxazolyl, phthalazinyl, picolinyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyridinyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, thiazolyl, thienyl, triazinyl, and tetrazolyl; with the proviso that if R1 is H, then R5 is (CH2)rNR5aR5a; and with the further proviso that if R5 is H, then R1 is not H or methyl;
R2 is selected from phenyl substituted with 0-2 R7, and a 5-10 membered heteroaryl system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R7 wherein the heteroaryl is selected from indolyl, benzimidazolyl, benzofuranyl, benzothiofuranyl, benzoxazolyl, benzthiazolyl, benztriazolyl, benztetrazolyl, benzisoxazolyl, benzisothiazolyl, benzimidazalonyl, cinnolinyl, furanyl, imidazolyl, indazolyl, indolyl, isoquinolinyl isothiazolyl, isoxazolyl, oxazolyl, phthalazinyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyridinyl, pyrimidinyl, pyrrolyl, pyrrolotriazinyl, quinazolinyl, quinolinyl, thiazolyl, thienyl, and tetrazolyl;
R5, at each occurrence, is independently selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, allyl, propynyl, F, Cl, Br, I, (CH2)rOH, (CH2)rOR5d, (CH2)rNR5aR5a, (CH2)rC(O)R5b, (CH2)rC(O)NR5aR5a, (CH2)rNR5aC(O)R5b, (CH2)rOC(O)NR5aR5a, (CH2)rNR5aC(O)OR5d, (CH2)rNR5aC(O)R5b, (CH2)rC(O)OR5b, (CH2)rOC(O)R5b, (CH2)rNR5aS(O)2R5b, and C1-6 haloalkyl, (CH2)rphenyl substituted with 0-2 R5e, and a (CRR)r-5-10 membered heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-2 R5c, wherein the heterocyclic system is selected from pyrrolidinyl, piperidinyl, and morpholinlyl;
R5a, at each occurrence, is independently selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, pentyl, hexyl, cyclopropyl, and cyclobutyl;
R5b, at each occurrence, is selected from C1-6 alkyl substituted with 0-3 R5e, C1-6 haloalkyl, C3-8 alkenyl substituted with 0-2 R5e, C3-8 alkynyl substituted with 0-2 R5e, a (CH2)r—C3-6 carbocyclic residue substituted with 0-2 R5e, and a (CH2)r-5-6 membered heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R5e;
R5c, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, Br, I, F, (CF2)rCF3, NO2, CN, (CH2)rNR5fR5f, (CH2)rOH, (CH2)rOC1-4 alkyl, (CH2)rSC1-4 alkyl, (CH2)rC(O)OH, (CH2)rC(O)R5b, (CH2)rC(O)NR5fR5f, (CH2)rOC(O)NR5fR5f, (CH2)rNR5fC(O)R5b, (CH2)rC(O)OC1-4 alkyl, (CH2)rNR5fC(O)OC1-4 alkyl, (CH2)rOC(O)R5b, (CH2)rC(═NR5f)NR5fR5f, (CH2)rS(O)pR5b, (CH2)rNHC(═NR5f)NR5fR5f, (CH2)rS(O)2NR5fR5f, (CH2)rNR5fS(O)2R5b, C(O)OH, (CH2)rC(O)NHSO2R5h, NHSO2—R5h, (CH2)rtetrazolyl, and (CH2)rphenyl substituted with 0-3 R5e;
R5d, at each occurrence, is selected from methyl, CF3, C2-6 alkyl substituted with 0-2 R5e, C3-8 alkenyl substituted with 0-2 R5e, C3-8 alkynyl substituted with 0-2 R5e, and a C3-10 carbocyclic residue substituted with 0-3 R5e;
R5e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, SH, (CH2)rSC1-5 alkyl, (CH2)rNR5fR5f, (CH2)rC(O)NHR5h, (CH2)rOC(O)NHR5h, (CH2)rOH, (CH2)rC(O)OH, (CH2)rC(O)NHSO2—R5h, NHSO2R5h, a (CH2)r-5-6 membered heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, and (CH2)rphenyl;
R5f, at each occurrence, is selected from H, C1-6 alkyl, and C3-6 cycloalkyl;
R5h, at each occurrence, is selected from C1-5 alkyl, C1-5 haloalkyl, and C3-6 cycloatkyl, and phenyl;
R, at each occurrence, is independently selected from H, methyl, ethyl, propyl, allyl, propynyl, (CH2)rC3-6 cycloalkyl, and (CH2)rphenyl substituted with R5e;
R6, at each occurrence, is selected from C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, Br, I, F, NO2, CN, (CH2)rNR6a′R6a′, (CH2)rOH, (CH2)rO(CH2)rR6d, (CH2)rSH, (CH2)rC(O)H, (CH2)rS(CH2)rR6d, (CH2)rC(O)OH, (CH2)rC(O)(CH2)rR6b, (CH2)rC(O)NR6aR6a, (CH2)rNR6fC(O)R6b′, (CH2)rNR6aC(O)NR6a′R6d′, (CH2)rNR6aC(S)NR6aR6a, (CH2)rOC(O)(CH2)rR6b, (CH2)rS(O)pR6b′, (CH2)rS(O)2NR6aR6a, (CH2)rNR6fS(O)2(CH2)rR6b, (CH2)rNR6fS(O)2NR6aR6a, C1-6 haloalkyl, (CH2)rphenyl substituted with 0-3 R6e, and a (CH2)r-5-6 membered heterocyclic system containing 1-2 heteroatoms selected from N, O, and S, substituted with 0-2 R6e, wherein the heterocyclic system is selected from aziridinyl, azetidinyl, pyrrolyl, piperidinyl, and morpholinyl;
R6a, at each occurrence, is independently selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl and phenyl;
R6a′, at each occurrence, is selected from H, C1-6 alkyl and C3-6 cycloalkyl;
R6b, at each occurrence, is selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl, and phenyl;
R6b′, at each occurrence, is selected from H, C1-6 alkyl and C3-6 cycloalkyl;
R6d, at each occurrence, is selected from methyl, CF3, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl, and phenyl;
R6d′, at each occurrence, is selected from H, CF3 and C1-6 alkyl and C3-6 cycloalkyl;
R6e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, SH, (CH2)rSC1-5 alkyl, (CH2)rNR6fR6f, C(O)NHR6h, C(O)OC1-5 alkyl, (CH2)rOH, C(O)OH, (CH2)rC(O)NHSO2—R6h, NHSO2R6h, (CH2)rtetrazolyl, (CH2)rphenyl and a (CH2)r-5-6 membered heterocyclic system containing 1-4 heteroatoms selected from N, O, and S;
R6f, at each occurrence, is selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl, and phenyl;
R6h, at each occurrence, is selected from C1-5 alkyl, C1-5 haloalkyl, and C3-6 cycloalkyl, and phenyl;
R7 is selected from methyl, ethyl, propyl, i-propyl, butyl, i-butyl, s-butyl, t-butyl, pentyl, hexyl, (CH2)rC3-6 cycloalkyl, Cl, Br, I, F, NO2, CN, (CH2)rNR7aR7a, (CH2)rOH, (CH2)rO(CH2)rR7d, (CH2)rSH, (CH2)rC(O)H, (CH2)rS(CH2)rR7d, (CH2)rC(O)OH, (CH2)rC(O)(CH2)rR7b, (CH2)rC(O)NR7aR7a, (CH2)rNR7fC(O)(CH2)rR7b, (CH2)rC(O)O(CH2)rR7d, (CH2)rOC(O)(CH2)rR7b, (CH2)rOC(O)NR7aR7a, (CH2)rNR7aC(O)NR7aR7a, (CH2)rNR7aC(O)O(CH2)rR7d, (CH2)rS(O)p(CH2)rR7b, (CH2)rS(O)2NR7aR7a, (CH2)rNR7fS(O)2(CH2)rR7b, C1-6 haloatkyl, adamantyl, (CH2)rphenyl substituted with 0-3 R7e, and a (CH2)r-5-6 membered heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R7e, wherein the heterocyclic system is selected from thienyl, pyridinyl, benzothiazolyl, and tetrazolyl;
R7a, at each occurrence, is selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, prop-2-enyl, 2-methyl-2-propenyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, CH2cyclopropyl, and benzyl;
R7b, at each occurrence, is selected from methyl, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl, cyclopentyl, CH2-cyclopentyl, cyclohexyl, CH2-cyclohexyl, CF3, pyrrolidinyl, morpholinyl, piperazinyl, piperidinyl, substituted with 0-1 R7e, and azetidinyl;
R7d, at each occurrence, is selected from methyl, CF3, CF2CF3, CHF2, CH2F, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, and cyclopropyl;
R7e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, (CH2)rOH, OH, SH, C(O)OH, C(O)NHR7h, C(O)OC1-5 alkyl, (CH2)rSC1-5 alkyl, (CH2)rNR7fR7f, (CH2)rC(O)NHSO2—R7h, NHSO2R7h, and (CH2)rphenyl, and (CH2)rtetrazolyl;
R7f, at each occurrence, is selected from H, methyl, ethyl, propyl, i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl, and phenyl;
R7h, at each occurrence, is selected from C1-5 alkyl, C1-5 haloalkyl, and C3-6 cycloalkyl, and phenyl;
R8 is selected from H, methyl, ethyl, propyl, i-propyl, and cyclopropyl;
R9 is selected from H, C1-4 alkyl, C3-4 cycloalkyl, —C(O)H, and —C(O)—C1-4alkyl;
R10 is H;
R11 is selected from H, C1-4 alkyl, (CHR)qOH, (CHR)qSH, (CHR)qOR11d, (CHR)qS(O)pR11d, (CHR)rC(O)R11b, (CHR)rNR11aR11a, (CHR)rC(O)NR11aR11a, (CHR)rC(O)NR11aOR11d, (CHR)qNR11aC(O)R11b, (CHR)qNR11aC(O)OR11d, (CHR)qOC(O)NR11aR11a, (CHR)rC(O)OR11d, a (CHR)r—C3-6 carbocyclic residue substituted with 0-5 R11e, and a (CHR)r-5-10 membered heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R11e;
R11a, at each occurrence, is independently selected from H, C1-4 alkyl, C3-4 alkenyl, C3-4 alkynyl, (CH2)rC3-6 cycloalkyl, and a (CH2)r-5-6 membered nonaromatic heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R11e;
R11b, at each occurrence, is independently selected from C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, a (CH2)r-C3-6 cycloalkyl substituted with 0-2 R11e, and a (CH2)r-5-6 membered nonaromatic heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R11e;
R11d, at each occurrence, is independently selected from H, methyl, —CF3, C2-4 alkyl, C3-6 alkenyl, C3-6 alkynyl, a C3-6 cycloalkyl substituted with 0-3 R11e, and a (CH2)r-5-6 membered nonaromatic heterocyclic system containing 1-4 heteroatoms selected from N, O, and S, substituted with 0-3 R11e;
R11e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, —O—C1-6 alkyl, SH, (CH2)rSC1-5 alkyl, (CH2)rNR11fR11f, and (CH2)rphenyl;
R11f, at each occurrence, is selected from H, C1-6 alkyl, and C3-6 cycloalkyl;
R12 is selected from H, C1-4 alkyl, and a (CHR)r—C3-6 carbocyclic residue substituted with 0-5 Rl2e;
Rl2e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, —O—C1-6 alkyl, SH, (CH2)rSC1-5 alkyl, (CH2)rNR12fR12f, and (CH2)rphenyl;
R12f, at each occurrence, is selected from H, C1-6 alkyl, and C3-6 cycloalkyl;
R13, at each occurrence, is independently selected from H, and C1-4 alkyl substituted with 0-1 Rl3b, —OH, —NH2, F, Cl, Br, I, —OR13a, —N(Rl3a)2, and C1-4 alkyl substituted with 0-3 Rl3b;
R13a is selected from H, C1-4 alkyl and C3-6 cycloalkyl;
Rl3b, at each occurrence, is independently selected from —OH, —SH, —NRl3cRl3c, —C(O)NRl3cRl3c, and —NHC(O)Rl3c;
Rl3c is selected from H, C1-4 alkyl and C3-6 cycloalkyl;
R14, at each occurrence, is independently selected from H and C1-4 alkyl;
alternatively, two R14s, along with the carbon atom to which they are attached, join to form a C3-6 carbocyclic ring;
R15, at each occurrence, is independently selected from H, C1-4alkyl, OH, NH2, —O—C1-4 alkyl, NR15aRl5a, C(O)NR15aR15a, NR15aC(O)R15b, NR15aC(O)OR15d, OC(O)NR15aR15a, and (CHR)rC(O)OR15d;
alternatively, two R15s, along with the carbon atom or atoms to which they are attached, join to form a C3-6 carbocyclic ring;
R15a, at each occurrence, is independently seleced from H, and C1-4 alkyl;
R15b, at each occurrence, is independently selected from C1-4 alkyl, C3-6 alkenyl, and C3-6 alkynyl;
R15d, at each occurrence, is independently selected from C1-4 alkyl, C3-6 alkenyl, and C3-6 alkynyl;
R16 is selected from C1-4 alkyl;
n is 1;
m is selected from 0 and 1;
p, at each occurrence, is independently selected from 0, 1, and 2;
q, at each occurrence, is independently selected from 1, 2, 3, and 4;
r is 0 or 1; and
s is 0.